Fundz

Cardiomech Raises $13M In Heavily Oversubscribed Round For Its Transcatheter Mitral Chordal Repair Technology

PRIVATEJan 02, 2024

Amount Raised

$13 Million

Round Type

Funding Round

ManufacturingBiotechnology

Description

Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, today announced it has closed on $13M in fresh capital ($42M to-date). CardioMech received strong financial support from existing and new investors, including a non-disclosed strategic investor.

Quick answer

CardioMech AS raised $13 Million in a Funding Round round, dated January 2, 2024.

How much did CardioMech AS raise?
CardioMech AS raised $13 Million in a Funding Round round on January 2, 2024.
What does CardioMech AS do?
CardioMech develops devices for structural heart disease, offering alternatives to cardiac surgery, specifically for mitral valve issues.
Who are the decision-makers at CardioMech AS?
Fundz holds 1 contact at CardioMech AS, including the Chief Operation Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as CardioMech AS that raised within 45 days of this round, from Fundz verified event records.

  • valisure llc raised $4M (Seed) on February 16, 2024.
  • TendoNova raised $602K (Seed) on February 15, 2024.
  • Ensysce Biosciences raised $4.7M (Seed) on February 14, 2024.
  • Sway raised $5M (Funding Round) on February 13, 2024.
  • Shape Memory Medical raised $30M on February 6, 2024.
  • Procyrion raised $58M (Series E) on February 5, 2024.

Who to call at CardioMech AS, and when

A new round usually means CardioMech AS is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CardioMech AS raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CardioMech AS, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CardioMech AS. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CardioMech AS

About

CardioMech develops devices for structural heart disease, offering alternatives to cardiac surgery, specifically for mitral valve issues.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CardioMech AS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJohn B., Chief Operation Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CardioMech AS's next move

See what Strategic adds

CardioMech AS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.